Management of abdominal endograft infection.

Department of Surgery, Vascular and Endovascular Surgery Unit, University of Siena, Siena, Italy.
The Journal of cardiovascular surgery (Impact Factor: 1.51). 02/2010; 51(1):33-41.
Source: PubMed

ABSTRACT Incidence, clinical presentation and management of aortic grafts infection after open surgical repair are well described in the literature. Infective complications involving endografts after endovascular aneurysm repair (EVAR) have been scarcely investigated, since more attention has been given to the technical aspects of the procedure, including endoleaks, device migration, neck dilatation, endotension and aneurysm rupture. Nevertheless, that is a rare but severe complication occurring after EVAR; potentially difficult to diagnose and treat. Since 1991 only 102 cases of abdominal endograft infections have been reported in the literature. Treatment of infected abdominal endografts is controversial. Although reports have shown that high-risk patients with infected stent grafts treated conservatively with antimicrobial therapy and percutaneous drainage can still survive, most authors agree that an infected endograft should be removed if patient's conditions allow intervention. Standard treatment for infected abdominal endografts includes complete graft excision and local debridement followed by extra-anatomical bypass revascularization or in situ reconstruction with an aortic-bisiliac or bifemoral graft (Dacron or PTFE) or with a homograft. Lower overall mortality was observed for surgical management by explantation of infected endograft followed by in situ replacement as compared to other surgical solutions, but no definitive conclusions can be drawn about the optimal treatment strategy for aortic reconstruction.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Silver exhibits excellent antimicrobial properties and is used to protect medical devices from microbial colonization. Because few data are available on the influence of silver coating of vascular prostheses on Candida biofilm formation, this study aimed to investigate the effect of silver on yeast biofilm formation in an in vitro model. Prosthesis material was co-cultivated with two different strains of Candida albicans and the effect of silver on attachment and the growth of biofilms was monitored by microscopy and by quantification of cfu and mitochondrial dehydrogenase activity. Silver collagen-coated vascular prostheses significantly reduced C. albicans biofilm formation in serum-free medium. Paradoxically, in the presence of 50% serum, silver increased the growth of biofilms on silver-containing prostheses 2- to 10-fold compared with silver-free prostheses. Silver ion concentrations between 1.7 and 0.17 mg/L, corresponding roughly to 1/20 to 1/200 of the MIC of silver nitrate, stimulated biofilm formation by C. albicans. Serum proteins reduced the concentration of silver ions delivered from the surface of vascular prostheses to a subinhibitory level, which stimulated the attachment and biofilm formation of C. albicans on grafts. Silver collagen coating therefore seems to be unsuitable for the prevention of growth of C. albicans on vascular prostheses under physiological conditions.
    Journal of Antimicrobial Chemotherapy 01/2014; · 5.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present three cases of stent graft infection that were treated with preservation of the endograft. In the first patient, the contamination of the endograft was the consequence of a bleeding aortoenteric fistula, whereas, in the second patient, the endograft was implanted into a ruptured contaminated aortic aneurysm due to the patient's haemodynamic instability. In the third case, the presence of a consistent type Ia endoleak after a chimney graft procedure followed by secondary interventions led to an infection of the stent graft. In each case, a laparotomy was performed with debridement, followed by appropriate antibiotic therapy. The first patient suffered a fatal pulmonary embolism. The other two patients are alive 4 and 24 months after the diagnosis of endograft infection. In unstable patients or those with severe comorbidities who cannot tolerate endograft excision and aortic reconstruction, surgical debridement followed by appropriate antibiotic therapy can be a temporary or bridging solution.
    Annals of Vascular Surgery 01/2014; · 0.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Both surgical and endovascular grafts have the rare risk of late secondary infection. Treatment varies based on the clinical setting, but in general the recommendations are that infected endografts be removed and reconstruction performed. In the abdominal aorta this may vary from homograft or other impregnated grafts to excision and extra-anatomic bypass. We discuss an unusual case which we believe serves as a useful review of this still debated area. A 58-year-old male presented with abdominal and back pain. Prior history was notable for human immunodeficiency virus positive status, pulmonary embolism (currently on Coumadin) and two years previously repair of a saccular infra-renal aneurysm with tube graft. The week prior to the onset of symptoms he suffered a noticeable scratch from his cat. Blood cultures were positive for pasturella multicoda. He was transferred to our institution and underwent resection and explantation, with homograft reconstruction. At one year he is alive and well.
    World journal of radiology. 01/2013; 5(1):17-19.